Sign inGet started

Ren Ken Keyong

Insider CIK 1545181 · ENMD Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CASI CASI Pharmaceuticals, Inc. A Award deriv2019-06-202019-06-2151,538— $051,538SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2019-01-292019-01-3175,000— $075,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2018-12-032018-12-06720,000— $0720,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2016-10-032016-10-05308,571— $0308,571SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2016-06-242016-06-2786,486— $086,486SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2016-06-022016-06-03280,701— $0280,701SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2016-03-022016-03-04125,000— $0125,000SEC↗
CASI CASI Pharmaceuticals, Inc. P Buy2016-01-192016-01-217,537$0.73 $5.5K7,537SEC↗
CASI CASI Pharmaceuticals, Inc. P Buy2016-01-192016-01-211,100$0.74 $8148,637SEC↗
CASI CASI Pharmaceuticals, Inc. P Buy2016-01-192016-01-216,063$0.72 $4.4K14,700SEC↗
CASI CASI Pharmaceuticals, Inc. P Buy2016-01-192016-01-21300$0.71 $21315,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2015-04-062015-04-08225,000— $0225,000SEC↗
CASI CASI Pharmaceuticals, Inc. A Award deriv2014-04-032014-11-14100,000— $0100,000SEC↗
ENMD ENTREMED INC A Award deriv2014-04-032014-04-04150,000— $0150,000SEC↗
ENMD ENTREMED INC A Award deriv2013-05-302013-05-311,000,000— $01,000,000SEC↗
ENMD ENTREMED INC A Award deriv2012-04-022012-04-03150,000— $0150,000SEC↗